1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 4
FEATURED COMPANIES
- Abbott
- BIOTRONIK
- Boston Scientific
- Medtronic
- MORE
Technological advances to drive growth in the market. Technological advances such as the introduction of quadripolar lead devices, improvements in patient monitoring to avoid needless shocks, and development of MRI safe ICDs have significantly improved the reliability and effectiveness of ICDs. The analysts have predicted that the implantable cardioverter defibrillators market will register a CAGR of almost 2% by 2022.
Market Overview
Increasing prevalence of cardiac arrhythmias
Prevalence of cardiac arrhythmias is steadily increasing. With the rise in cardiac disorders the demand for implantable cardioverter defibrillators will also increase.
Device limitations and complications
ICDs have been associated with many undesirable effects such as lead failures, deterioration in the quality of life, repeated in appropriate shocks, and premature battery complications.
For the detailed list of factors that will drive and challenge the growth of the implantable cardioverter defibrillators market during the 2018-2022, view this report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Abbott and BIOTRONIK, the competitive environment is quite intense. Factors such as the technological advances and the increasing prevalence of cardiac arrhythmias, will provide considerable growth opportunities to implantable cardioverter defibrillators manufactures. Abbott, BIOTRONIK, Boston Scientific, and Medtronic are some of the major companies covered in this report.
Market Overview
Increasing prevalence of cardiac arrhythmias
Prevalence of cardiac arrhythmias is steadily increasing. With the rise in cardiac disorders the demand for implantable cardioverter defibrillators will also increase.
Device limitations and complications
ICDs have been associated with many undesirable effects such as lead failures, deterioration in the quality of life, repeated in appropriate shocks, and premature battery complications.
For the detailed list of factors that will drive and challenge the growth of the implantable cardioverter defibrillators market during the 2018-2022, view this report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Abbott and BIOTRONIK, the competitive environment is quite intense. Factors such as the technological advances and the increasing prevalence of cardiac arrhythmias, will provide considerable growth opportunities to implantable cardioverter defibrillators manufactures. Abbott, BIOTRONIK, Boston Scientific, and Medtronic are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- Abbott
- BIOTRONIK
- Boston Scientific
- Medtronic
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 10: REGIONAL LANDSCAPE
PART 12: DRIVERS AND CHALLENGES
Exhibit 01: Global cardiac implants market
Exhibit 02: Global cardiac implants market - Segments
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global ICD market 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global ICD market - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global ICD market - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global ICD market - Market share by product 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global regular ICD market - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global regular ICD market - Year-over-year growth 2018-2022 (%)
Exhibit 22: Global CRT-D market - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global CRT-D market - Year-over-year growth 2018-2022 (%)
Exhibit 24: Global S-ICD market - Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Global S-ICD market - Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Global ICD market - Market share by region 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: ICD market in Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 31: ICD market in Americas - Year-over-year growth 2018-2022 (%)
Exhibit 32: Top three countries in Americas
Exhibit 33: ICD market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 34: ICD market in EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 35: Top three countries in EMEA
Exhibit 36: ICD market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 37: ICD market in APAC - Year-over-year growth 2018-2022 (%)
Exhibit 38: Top three countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: ICD new implant rates per 100,000 population between 2010 and 2015
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott - Overview
Exhibit 47: Abbott - Business segments
Exhibit 48: Abbott - Organizational developments
Exhibit 49: Abbott - Geographic focus
Exhibit 50: Abbott - Segment focus
Exhibit 51: Abbott - Key offerings
Exhibit 52: Abbott - Key customers
Exhibit 53: BIOTRONIK - Overview
Exhibit 54: BIOTRONIK - Business segments
Exhibit 55: BIOTRONIK - Organizational developments
Exhibit 56: BIOTRONIK - Key offerings
Exhibit 57: BIOTRONIK - Key customers
Exhibit 58: Boston Scientific - Overview
Exhibit 59: Boston Scientific - Business segments
Exhibit 60: Boston Scientific - Organizational developments
Exhibit 61: Boston Scientific - Geographic focus
Exhibit 62: Boston Scientific - Segment focus
Exhibit 63: Boston Scientific - Key offerings
Exhibit 64: Boston Scientific - Key customers
Exhibit 65: Medtronic - Overview
Exhibit 66: Medtronic - Business segments
Exhibit 67: Medtronic - Organizational developments
Exhibit 68: Medtronic - Geographic focus
Exhibit 69: Medtronic - Segment focus
Exhibit 70: Medtronic - Key offerings
Exhibit 71: Medtronic - Key customers
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Segmentation by product
- Comparison by product
- Regular ICD
- CRT-D
- S-ICD
- Market opportunity by product
- Hospitals and clinics
- ASCs
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- ICD market in Americas
- ICD market in EMEA
- ICD market in APAC
- Market opportunity
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Technological advances
- Increasing popularity of remote monitoring and follow-up of ICDs
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- BIOTRONIK
- Boston Scientific
- Medtronic
- List of abbreviations
Exhibit 01: Global cardiac implants market
Exhibit 02: Global cardiac implants market - Segments
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global ICD market 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global ICD market - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global ICD market - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global ICD market - Market share by product 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global regular ICD market - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global regular ICD market - Year-over-year growth 2018-2022 (%)
Exhibit 22: Global CRT-D market - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global CRT-D market - Year-over-year growth 2018-2022 (%)
Exhibit 24: Global S-ICD market - Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Global S-ICD market - Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Global ICD market - Market share by region 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: ICD market in Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 31: ICD market in Americas - Year-over-year growth 2018-2022 (%)
Exhibit 32: Top three countries in Americas
Exhibit 33: ICD market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 34: ICD market in EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 35: Top three countries in EMEA
Exhibit 36: ICD market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 37: ICD market in APAC - Year-over-year growth 2018-2022 (%)
Exhibit 38: Top three countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: ICD new implant rates per 100,000 population between 2010 and 2015
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott - Overview
Exhibit 47: Abbott - Business segments
Exhibit 48: Abbott - Organizational developments
Exhibit 49: Abbott - Geographic focus
Exhibit 50: Abbott - Segment focus
Exhibit 51: Abbott - Key offerings
Exhibit 52: Abbott - Key customers
Exhibit 53: BIOTRONIK - Overview
Exhibit 54: BIOTRONIK - Business segments
Exhibit 55: BIOTRONIK - Organizational developments
Exhibit 56: BIOTRONIK - Key offerings
Exhibit 57: BIOTRONIK - Key customers
Exhibit 58: Boston Scientific - Overview
Exhibit 59: Boston Scientific - Business segments
Exhibit 60: Boston Scientific - Organizational developments
Exhibit 61: Boston Scientific - Geographic focus
Exhibit 62: Boston Scientific - Segment focus
Exhibit 63: Boston Scientific - Key offerings
Exhibit 64: Boston Scientific - Key customers
Exhibit 65: Medtronic - Overview
Exhibit 66: Medtronic - Business segments
Exhibit 67: Medtronic - Organizational developments
Exhibit 68: Medtronic - Geographic focus
Exhibit 69: Medtronic - Segment focus
Exhibit 70: Medtronic - Key offerings
Exhibit 71: Medtronic - Key customers
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
FEATURED COMPANIES
- Abbott
- BIOTRONIK
- Boston Scientific
- Medtronic
- MORE
Global Implantable Cardioverter Defibrillators Market 2018-2022
The analyst recognizes the following companies as the key players in the global implantable cardioverter defibrillators market: Abbott, BIOTRONIK, Boston Scientific, and Medtronic.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances.”
According to the report, one of the major drivers for this market is the increasing prevalence of cardiac arrhythmias.
Further, the report states that one of the major factors hindering the growth of this market is the device limitations and complications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
The analyst recognizes the following companies as the key players in the global implantable cardioverter defibrillators market: Abbott, BIOTRONIK, Boston Scientific, and Medtronic.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances.”
According to the report, one of the major drivers for this market is the increasing prevalence of cardiac arrhythmias.
Further, the report states that one of the major factors hindering the growth of this market is the device limitations and complications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
- Abbott
- BIOTRONIK
- Boston Scientific
- Medtronic
Note: Product cover images may vary from those shown
